Pharma Regulatory Submission Software
Coordinate NDA, BLA, IND, and supplement execution in one submission workspace. Keep drafting, validation, and cross-functional review aligned without adding headcount.
Pharma Submission Workflow
See where Pharma teams lose time across drafting, review, validation, and partner coordination.
Ship NDAs Without the 4-Week Integration Phase
Standardized NDA workflows handle module structure, lifecycle operations, and cross-module references. The integration phase where CMC, clinical, and nonclinical packages get stitched together disappears into the authoring workflow itself.
Keep Every Supplement Cycle Audit-Ready
Commercial pharma runs dozens of supplements a year: CMC changes, labeling updates, safety additions. Each one carries its own lifecycle dependencies. Assyro preserves the trail automatically so any supplement decision is retrievable years later.
Handle PDUFA Reviews Without the T-30 Panic
Continuous readiness scoring shows program status across portfolios, flagging the one program that's actually at risk instead of treating every filing as equally urgent. Leaders stop running PDUFA by fire drill.
Run Global and US Programs Off the Same Content
Shared Modules 3, 4, 5 content feeds US, EU, and ex-US filings without rebuilding. Region-specific Module 1 content stays separate. Commercial pharma teams stop rewriting the same clinical summary three times.
Pharma Workflow Controls at Scale
Keep submission growth controlled with clearer ownership, better traceability, and consistent execution across active programs.
Maintain Audit-Ready Submission Workflows
21 CFR Part 11, ICH CTD/eCTD, FDA guidance aligned workflows with audit trails, role-based access, and submission traceability.
Manage More Pharma Programs With the Same Team Size
Onboard new RA staff in days with reusable, pre-configured submission workflows
Questions About Pharma Workflows
Practical questions buyers ask when evaluating pharma regulatory submission software.
